Healthcare Industry News: TomoTherapy
News Release - March 27, 2007
Institute Curie Hospital, First in France to Install TomoTherapy(R) Hi-Art(R) treatment systemMADISON, Wis.--(HSMN NewsFeed)--TomoTherapy Incorporated announced today that France's Institute Curie Hospital has acquired the first TomoTherapy Hi-Art system to be used in France. The Institute Curie Hospital announced the acquisition with a tour of the treatment area and a reception hosted by Professor Claude Huriet, President of the Institute Curie, on March 7th, 2007. Notable attendees included Professor Dominque Maranchi, President of the National Institute of Cancer (INCA) and Marc Lipinski, Vice-President of the Regional Council, IIe-de-France.
A private foundation comprised of France's largest cancer research center and a leading public hospital, the Institute Curie was founded in 1909 by Marie Curie. Since receiving state approval in 1921, the Institute Curie has made developing innovative and individualized treatments, and ensuring availability of the most advanced techniques, among its chief priorities.
"We are pleased to have the TomoTherapy Hi-Art system being used by a pioneering institution so notably linked to the field of radiation," said TomoTherapy Inc. CEO, Dr. Fred Robertson.
The decision by the Institute Curie Hospital to install the TomoTherapy Hi-Art system follows calls for research proposals launched by the National Cancer Institute in July 2005 to promote implementation of image-guided radiation therapy technology that was not previously available in France. Two other centers in France, Nantes and Bordeaux, intend to install the TomoTherapy Hi-Art system as a result of the proposals' recommendations.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, manufactures and sells the Hi-ArtŪ system, one of the most advanced and versatile radiation therapy systems commercially available for the treatment of a wide variety of cancers. TomoTherapy Incorporated markets the Hi-ArtŪ system to hospitals and cancer treatment centers in North America, Europe and Asia.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.